SC

Sheatree Capital

North America, New York, United States, Florida

Description

Sheatree Capital operates an investment firm.

Investor Profile

Sheatree Capital has made 2 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sheatree Capital frequently co-invest with?

Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Playground Global
North America, California, United States, Palo Alto
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Qatar Investment Authority
Asia, Ad Dawhah, Qatar, Doha
Co-Investments: 1
Breton Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
Abstract Ventures
North America, California, United States, San Francisco
Co-Investments: 1
BO
North America, New York, United States, New York
Co-Investments: 1
Mubadala Capital
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1

Which angels does Sheatree Capital often collaborate with?

RS
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by Sheatree Capital?

Outpace Bio

Seattle, Washington, United States

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BAug 1, 2024
Amount Raised: $144,000,000
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownJun 27, 2024
Amount Raised: $20,000,000